PharmaCyte Biotech, Inc.
- Last sale
- Oct 30, 2026 · -12.07%
- Market cap
- $3.28M
- 10.74M shares
- Filings
- 473
Q1 2027
Q1 2027N/M FY26 yoy
Q1 2027N/M FY26 yoy
—
—
—Q1 2027N/M FY26 yoy
Q1 2027+22.6% FY26 yoy
- $3.28M
- —
- —
- 0.1×
- —
- —
Twelve months to Jul 31, 2026 · derived
Price
Oct 30, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-04-30 | $0 | reported | |
| FY 2025 | 2025-04-30 | $0 | reported | |
| FY 2024 | 2024-04-30 | $0 | reported | |
| FY 2023 | 2023-04-30 | $0 | reported | |
| FY 2022 | 2022-04-30 | $0 | reported | |
| FY 2021 | 2021-04-30 | $0 | reported | |
| FY 2020 | 2020-04-30 | $0 | reported | |
| FY 2019 | 2019-04-30 | $0 | reported | |
| FY 2018 | 2018-04-30 | $0 | reported | |
| FY 2017 | 2017-04-30 | $0 | reported | |
| FY 2016 | 2016-04-30 | $0 | reported | |
| FY 2015 | 2015-04-30 | $0 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2026 | — | $401.63K | $401.63K | — | 10.74M sh | +58.0% | — |
| FY2025 | — | $2.54M | $2.54M | — | 6.80M sh | −11.9% | — |
| FY2024 | — | $28.20M | $28.20M | — | 7.71M sh | −12.2% | — |
| FY2023 | — | $13.56M | $13.56M | — | 8.78M sh | −57.7% | — |
| FY2022 | — | $0.00 | $0.00 | — | 20.75M sh | +0.1% | — |
Biological products, except diagnostic substances
PharmaCyte Biotech, Inc. is the 161st largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
AIMAIM ImmunoTech Inc.$88.0K48.2%15,861.4%$5.8MCRISCuris Inc$9.4M13.4%80.3%$5.5MCELZCreative Medical Technology Holdings, Inc.$6.0K45.5%99,916.8%$4.7MSNTISenti Biosciences Holdings, Inc.$22.0K—279,263.6%$4.6M
PMCBPharmaCyte Biotech, Inc. (this company)$0.0——$3.3M
VIVSVivoSim Labs, INC.$131.0K9.0%10,567.2%$2.8MABPOAbpro Holdings, Inc.———$2.5MCLDICalidi Biotherapeutics, Inc.———$2.3MBCABBioAtla, Inc.———$2.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
PharmaCyte Biotech, Inc. · CIK 1157075 · Engraved from SEC EDGAR